ORIGINAL RESEARCH
Published on 30 Nov 2020
Weichang’an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer—Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1
doi 10.3389/fphar.2020.512598
- 3,058 views
- 14 citations